InvestorsHub Logo
Followers 43
Posts 2425
Boards Moderated 0
Alias Born 02/09/2016

Re: Cynmark24 post# 20135

Tuesday, 02/20/2018 9:10:53 AM

Tuesday, February 20, 2018 9:10:53 AM

Post# of 233039
Cynmark24- yes, a good point to consider. Typical example is when earnings are rumored. This one is different for CYDY.
Thank you!
CYDY is opening their door with this PR. Much more of this is the potential of CYDY. Is it a good time to invest? What will be the value here in 3 mos? What competition are they up against?

To be quoted in todays PR from this gentleman speaks volumes for Pro-140 as a potential disruptive new treatment. Google him. He is the real deal.

“The standard approach to ART therapy has been to administer combinations of oral medications that must be taken daily,” said Robert T. Schooley, MD, Professor of Medicine, Department of Infectious Diseases and Global Public Health, University of California, San Diego. “Recently, there has been increasing interest in the development of drugs that do not require daily administration. I believe that PRO 140 is a step in that direction. These PRO 140 trial findings support the potential of managing HIV by blocking its entry into T cells through a novel humanized monoclonal antibody administered in weekly subcutaneous injections. "PRO 140 could provide an important new therapeutic option in suppressing a patient’s viral load as well as deterring the spread of this disease.”

Future earnings on the horizon for CYDY!!
Chump
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News